Ketoconazole
Nizoral
Ibogaine and Atorvastatin
Also known as: Lipitor
CYP3A4 substrate. Minimal direct interaction.
Severity
Minor — monitor
Mechanism
CYP3A4 metabolism overlap
Protocol Status
Pre-arrival washout (under your prescribing physician)
Restart Delay
Physician discretion
What "Minor — monitor" Means
Generally safe. May require a hold on dosing day or post-treatment monitoring depending on individual response.
Clinical Action
What our medical team does for patients on Atorvastatin.
Generally safe to continue. Can hold on treatment day.
Where the Washout Happens
Pre-arrival washout (under your prescribing physician)
Discontinuation is completed before arrival, under the patient's own prescribing physician, with the medication-specific washout interval observed before the flood dose.
Pre-Treatment Washout Window
Hold on dosing day; physician-directed timing.
Post-Treatment Restart
Restart at physician discretion once acute window closes.
The Pharmacology
How Atorvastatin interacts with ibogaine: cyp3a4 metabolism overlap.
CYP3A4 is the second major hepatic clearance pathway. Strong CYP3A4 inhibitors (some antifungals, macrolides, and protease inhibitors) extend the elimination of ibogaine and several co-medications, while strong inducers can cause sub-therapeutic exposure. Either direction destabilises a treatment that depends on tightly controlled plasma kinetics.
Same Mechanism
Other medications that interact via cyp3a4 metabolism overlap.
Same Severity Tier
Other minor — monitor medications (different mechanism).
Common Questions
Atorvastatin and ibogaine treatment.
Can I take ibogaine if I am on Atorvastatin?
Minor — monitor. CYP3A4 substrate. Minimal direct interaction. Generally safe to continue. Can hold on treatment day.
How long do I need to be off Atorvastatin before ibogaine treatment?
Pre-arrival washout (under your prescribing physician). Discontinuation is completed before arrival, under the patient's own prescribing physician, with the medication-specific washout interval observed before the flood dose. Hold on dosing day; physician-directed timing.
What is the mechanism of the interaction?
CYP3A4 metabolism overlap. CYP3A4 is the second major hepatic clearance pathway. Strong CYP3A4 inhibitors (some antifungals, macrolides, and protease inhibitors) extend the elimination of ibogaine and several co-medications, while strong inducers can cause sub-therapeutic exposure. Either direction destabilises a treatment that depends on tightly controlled plasma kinetics.
Can I switch to a different medication so I can have ibogaine treatment?
In many cases yes. Our medical team works with your prescribing physician to taper or substitute medications safely before treatment. The right substitution depends on the underlying condition you are treating with Atorvastatin — contact us for an individual review.
Checking more than one medication? Use the interactive Drug Interaction Checker to screen your full medication list at once.
Browse all 103 medications in the A–Z directory.
DA
Medically reviewed by Dr. Arellano, M.D.
Clinical Director, MindScape Retreat · Board-certified physician specializing in ibogaine-assisted detoxification with over 900 patients treated.
Last reviewed: May 2026 · See full medical team